Transarterial chemoembolization (TACE) in patients with unresectable diffuse vs. focal hepatocellular carcinoma (HCC).

被引：1
|
作者：
Pan, SH [1 ]
Ramirez, C [1 ]
Hoffman, A [1 ]
Sher, L [1 ]
Rojter, S [1 ]
Lopez, RR [1 ]
机构：
[1] St Vincents Med Ctr, Los Angeles, CA USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)86110-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1136
引用
收藏
页码：A991 / A991
页数：1
相关论文
共 50 条
  • [31] Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma
    Wang, Peng
    Sheng, Lili
    Wang, Guoxiang
    Wang, Heping
    Huang, Xinyu
    Yan, Xiaoxing
    Yang, Xiaohua
    Pei, Renguang
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 203 - 206
  • [32] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Andrew Burroughs
    Dimitrios Samonakis
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 78 - 79
  • [33] Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
    Tan, Bin-Bin
    Fu, Ying
    Shao, Ming-Hua
    Chen, Hai-Lei
    Liu, Ping
    Fan, Chao
    Zhang, Hui
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (09):
  • [34] Comparison of Conventional Transarterial Chemoembolization (TACE) and Chemoembolization With Doxorubicin Drug Eluting Beads (DEB) for Unresectable Hepatocelluar Carcinoma (HCC)
    Dhanasekaran, Renumathy
    Kooby, David A.
    Staley, Charles A.
    Kauh, John S.
    Khanna, Vinit
    Kim, Hyun S.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (06) : 476 - 480
  • [35] Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)
    Llovet, JM
    Real, MI
    Vilana, R
    Planas, R
    Coll, S
    Aponte, JJ
    Ayuso, C
    Sala, M
    Muchart, J
    Sola, R
    Rodes, J
    Bruix, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 11 - 11
  • [36] The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)
    Hanks, B. A.
    Suhocki, P. V.
    DeLong, D. M.
    Doan, P. L.
    Liu, E.
    Tsai, A. L.
    Burke, C. T.
    Bernard, S. A.
    O'Neil, B. H.
    Morse, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
    Geschwind, Jean-Francois H.
    Gholam, Pierre M.
    Goldenberg, Alec
    Mantry, Parvez
    Martin, Robert C. G.
    Piperdi, Bilal
    Zigmont, Ellen
    Imperial, Joanne
    Babajanyan, Svetlana
    Foreman, Pamela K.
    Cohn, Allen
    LIVER CANCER, 2016, 5 (01) : 37 - 46
  • [38] Outcomes of Patients (pts) with Hepatocellular Carcinoma (HCC) Treated with Transarterial Chemoembolization (TACE): Global OPTIMIS Final Analysis
    Peck-Radosavljevic, Markus
    Kudo, Masatoshi
    Raoul, Jean-Luc
    Lee, Han Chu
    Decaens, Thomas
    Heo, Jeong
    Lin, Shi-Ming
    Shan, Hong
    Yang, Yefa
    Bayh, Inga
    Nakajima, Keiko
    Cheng, Ann-Lii
    HEPATOLOGY, 2018, 68 : 167A - 168A
  • [39] Comparison between percutaneous ethanol injection (PEI) and transarterial chemoembolization (TACE) in patients with small hepatocellular carcinoma (HCC)
    Cioni, G
    Turrini, E
    Baraldi, E
    Pedrazzini, PG
    Ventura, E
    Ferrari, A
    D'Alimonte, P
    Ariosi, P
    De Santis, M
    JOURNAL OF HEPATOLOGY, 2000, 32 : 167 - 167
  • [40] Ischemic bile duct injury as a serious complication following transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC)
    Kim, HK
    Chung, YH
    Song, BC
    Youn, KH
    Lee, KN
    Yang, SH
    Hwang, JC
    Yoon, HK
    Yoo, ES
    Sung, KB
    Lee, YS
    Lee, SG
    Suh, DJ
    HEPATOLOGY, 1998, 28 (04) : 339A - 339A
12345